Physician profile
Luis E Duarte
NPI 1700867348
$1,231,515.72
in general payments reported to CMS, 2019-2025
43 companies · $182K in 2025
The $182K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142K · 2020: $103K · 2021: $166K · 2022: $224K · 2023: $207K · 2024: $207K · 2025: $182K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $489K · Consulting Fee: $106K · Food and Beverage: $2,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $488,614.91 |
| Consulting Fee | $105,775.00 |
| Food and Beverage | $2,352.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hyhte Holdings INC. | $586,047.20 | 2019-2025 | Olympic Mis, El Capitan, El Capitan O, Olympic Mis, Olympic Mis, El Capitan |
| Republic Spine | $356,856.75 | 2020-2025 | Interbody Fusion System Improvements, Nebula Expandable, Restore Line Extension |
| Depuy Synthes Products, INC. | $153,992.26 | 2019-2022 | |
| The Institute of Musculoskeletal Science and Education | $43,181.43 | 2020-2025 | Spira, Alcantara |
| Surgalign Spine Technologies, INC. | $40,854.29 | 2019-2021 | |
| Spinal Elements, INC. | $14,505.53 | 2020-2022 | |
| Amendia, INC. | $11,704.50 | 2019 | |
| Ulrich Medical USA, INC. | $10,446.15 | 2019-2025 | |
| Surgentec | $2,500.00 | 2025 | Ion |
| Globus Medical, INC. | $2,038.56 | 2019 | |
| Joimax, INC. | $2,000.00 | 2019 | |
| Intelivation Technologies, LLC | $1,750.00 | 2022 | |
| Camber Spine Technologies LLC | $1,698.57 | 2019-2023 | |
| Providence Medical Technology, INC. | $1,150.61 | 2019-2025 | |
| Abbott Laboratories | $943.79 | 2019-2025 | Infinity, Proclaim |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $371.57 | 2020-2025 | N/A |
| Meticuly INC. | $227.34 | 2024-2025 | Meticuly Patient-Specific Titanium Mesh Implant |
| Si-Bone, INC. | $163.56 | 2019-2025 | |
| Nevro Corp. | $144.07 | 2019 | |
| Intrinsic Therapeutics | $92.87 | 2025 | Barricaid Acd (Annular Closure Device) |
| Ethicon US, LLC | $76.10 | 2021 | |
| Xtant Medical INC | $73.50 | 2025 | |
| Siemens Medical Solutions USA, INC. | $72.53 | 2022 | |
| Spine Wave, INC. | $65.64 | 2019 | |
| Osseus Fusion Systems, LLC | $55.94 | 2019 | |
| Averitas Pharma INC. | $51.60 | 2025 | Qutenza |
| Pylant Medical | $51.51 | 2025 | |
| Relievant Medsystems, INC. | $51.50 | 2019 | |
| Integra Lifesciences Corporation | $43.36 | 2020 | |
| Medicrea USA, Corp. | $40.67 | 2019 | |
| Olympus America INC. | $27.48 | 2021 | |
| 7d Surgical Ulc | $27.17 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $26.92 | 2025 | |
| Osteomed LLC | $26.66 | 2021 | |
| Medtronic, INC. | $25.53 | 2023 | Percept PC Brainsense |
| Abbvie INC. | $20.15 | 2023 | Botox |
| Pacira Pharmaceuticals Incorporated | $19.82 | 2024 | Exparel |
| Viiv Healthcare Company | $19.36 | 2023 | Apretude |
| Mimedx Group, INC. | $18.82 | 2025 | |
| Aesculap, INC. | $14.51 | 2023 | Aesculap |
| Centinel Spine, LLC | $14.31 | 2019 | |
| Stimwave Technologies Incorporated | $12.72 | 2022 | |
| Ceribell, INC. | $10.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Duarte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.